Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Clinical and Novel Biomarkers in the Management of Prostate Cancer
Clinical outcomes in prostate cancer after initial screening and treatment for organ-confined disease and in advanced stage after drug intervention can be heterogeneous. Serum prostate-specific antigen which h...
-
Chapter
Management of Germ Cell Tumors
Germ cell tumors typically present in younger age populations and are known to be extremely sensitive to chemotherapy and radiation. As a result of this, remarkable progress has been achieved for offering a hi...